Pangaea Oncology Company Description

Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies.

It also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development.

Pangaea Oncology, S.A. was founded in 2006 and is based in Barcelona, Spain.

Pangaea Oncology, S.A.

Country	Spain
Founded	2006
Industry	Diagnostics & Research
Sector	Healthcare
Employees	149
CEO	Javier Rivela-Rodriguez

Contact Details

Address: Sabino Arana, 5-19 Barcelona, 08028 Spain
Phone	34 93 409 79 81
Website	panoncology.com

Stock Details

Ticker Symbol	PANG
Exchange	Madrid Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	ES0105221008
SIC Code	2836

Key Executives

Name	Position
Javier Rivela-Rodriguez C.F.A., M.B.A.	Co-Founder, Chief Executive Officer and Director
Dr. Rafael Rosell Costa M.D., Ph.D.	Chief Scientific Officer, President and Member of Scientific Committee
Alejandro Garcia Moncayo M.B.A.	Executive Director of Corporate and Chief Financial Officer
Carmen Albiol	Head of Operations for IOR
Dr. Miguel Angel Molina B.Sc., Ph.D.	Executive Director of Research and Development and Member of Scientific Committee
Alejandro Martinez M.D.	Chief Medical Officer and Medical Director at IOR (Hospital Universitari Dexeus)
Cristina Masferrer EMBA	Chief Business Officer
Juan Bezares Susin	Secretary of the Board